Structuring a Corporate Investment and Partnership in a Dutch BV

Category:

Corporate venture capital in a Dutch BV

Corporate venture capital (CVC) is an equity investment by an established company in a startup or growth business, usually combined with a strategic objective such as access to technology, product development, distribution or entry into a new market.

For a Dutch company, the investment and the strategic relationship should be structured together from the outset. The corporate may invest through one group entity, purchase products through another and rely on technology owned by a third. If those roles are not identified early, the investment agreement can be signed while the commercial arrangements supporting the investment remain incomplete.

When I review a CVC transaction, I therefore start by mapping the parties, funding flows and operational commitments. Who subscribes for the shares? Which entity is expected to buy, develop or distribute? Which rights belong in the shareholders’ agreement, which in the articles and which need a separate licence, development or supply agreement?

That exercise also determines what needs to be ready for the Dutch closing. The investment, governance rights, corporate approvals, notarial share issue and commercial agreements should form one workable transaction rather than a set of documents negotiated in parallel.

This article forms part of the series Corporate Venture Capital and Strategic Investments in Dutch Companies.

Identify the parties behind the commercial proposal

An industrial group may invest through its venture subsidiary while expecting another group company to purchase the startup’s products or incorporate its software into an existing platform. A separate entity may own the technology needed for joint development.

I would establish those roles before circulating the main transaction documents.

The Dutch company should know which entity is responsible for orders, development expenditure, technical support and access to distribution. Where performance depends on several affiliates, the documents should allocate those responsibilities expressly. A parent undertaking or guarantee may be appropriate where the proposed contracting entity has limited resources.

From the investor’s perspective, the same exercise prevents a venture team from promising commercial support that another business unit has not approved. The operational sponsor should be involved while those commitments are being negotiated.

Separate investment proceeds from commercial consideration

The transaction should distinguish capital paid into the Dutch BV from payments for products, development services or licences.

A subscription for new shares provides funding to the company. A purchase of existing shares pays the selling shareholder. A development fee compensates the company for agreed work. These payments have different purposes and should remain identifiable in the documentation and funds flow.

Suppose a corporate proposes EUR 4 million of equity funding together with a two-year development programme. The company needs to understand whether development costs are funded separately or must be met from the investment proceeds. That difference changes the amount available for its wider business.

A distribution commitment also needs a commercial basis. Introductions to potential customers, a procurement forecast and a binding minimum purchase obligation create different expectations. The agreement should reflect the commitment that the relevant business unit has actually authorised.

Allocate rights to the appropriate documents

The investment agreement deals with the funding, subscription terms, conditions and completion steps. The shareholders’ agreement records the continuing relationship between the shareholders. The articles support the relevant corporate rights. Commercial contracts address the product, licence, supply or development relationship.

I would prepare that document allocation with international lead counsel before drafting progresses. Their existing investment documents can remain the commercial starting point. The Dutch review identifies which provisions require local implementation and where separate obligations are needed from an operating affiliate.

The broader treatment of international investment terms appears in US-Style VC Terms in Dutch BV Documentation.

At this stage, I would also decide which commercial agreements must be signed before the investment completes. Where a licence or supply arrangement supports the investment decision, leaving it for negotiation after closing exposes both sides to a second negotiation after the shares have been issued.

Give the investor a workable governance position

Governance should reflect the corporate investor’s shareholding and the information it reasonably needs to monitor that investment.

A board appointment requires particular care. A director of a Dutch BV must act in the interests of the company and its business. Appointment by a corporate shareholder does not replace that duty with an obligation to follow the shareholder’s commercial instructions.

A dispute about the corporate’s supply contract may require a different decision-making and information process from the ordinary review of financial performance. The documents should anticipate how the relationship will be managed when the investor is also the company’s counterparty.

Information rights need similar attention. Financial reporting for the investment team should be distinguished from access to customer pricing, source code or product plans by the corporate’s operating businesses. I would agree the permitted recipients and uses of that information before routine reporting begins.

Coordinate the Dutch closing with the commercial start

The issue or transfer of Dutch BV shares requires a Dutch notarial deed. The underlying approvals and any applicable pre-emption arrangements must also be addressed.

The completion agenda should connect the share transaction with the commercial documents. It should identify when investment funds are released, when the licence becomes effective and whether any development or supply obligations start before or after completion.

For a foreign investor, I would arrange the notary’s identity, ownership and authority checks early. The proposed signatories and powers of attorney should be settled alongside the transaction documents.

Before signing, I would also test one straightforward scenario: the commercial partnership ends after eighteen months and the corporate remains a shareholder. The documents should identify which licences, information rights and cooperation obligations continue. Detailed separation arrangements can then be developed around that agreed outcome.

Practical conclusion

Before a corporate investor signs or completes an investment in a Dutch company, I would want the financial and strategic sides of the transaction to match.

The investment documents should identify who provides the capital and what shareholder rights follow from it. The commercial agreements should identify which group companies actually provide the promised customer access, development support, technology or distribution. Any rights that need Dutch corporate implementation should already be reflected in the articles, approvals and notarial closing steps.

I would also test what happens if the strategic relationship changes after the investment. A corporate may remain a shareholder after a pilot ends, a supply agreement terminates or the relevant business unit changes strategy. The documents should make clear which licences, information rights and other obligations survive in that situation.

For international lead counsel, that produces a much cleaner Dutch workstream: one agreed structure, one closing package and no unresolved gap between the equity investment and the commercial relationship.

FAQ

Should the investing entity also sign the commercial agreements?

Only where it is responsible for performing them. The relevant operating or IP-owning group company may need to sign separately.

Does buying existing shares finance the Dutch company?

The purchase price normally goes to the selling shareholder. Any additional funding for the company must be structured separately.

Does terminating the commercial agreement end the shareholding?

Not automatically. Any link between termination and a share transfer, option or change in investor rights must be agreed and legally implemented.

About Dirk de Waard

Dirk de Waard is a Dutch corporate, M&A and venture capital lawyer and partner at Venture Lawyers in Amsterdam. He advises corporate investors, founders and international counsel on Dutch investments, shareholder arrangements and commercial partnerships.

Structuring a corporate investment in a Dutch company?

Contact Dirk at dirk.dewaard@viottalaw.com to discuss the investment structure and commercial commitments. He can handle the Dutch venture capital workstream, work alongside international lead counsel and coordinate the shareholder documentation and Dutch notarial closing.

By VIOTTA.

Recent cases.

This is what we do best.

Expertise.